Panel Discussion: BMT As a Critical Treatment Option for AL

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Panel Discussion: BMT As a Critical Treatment Option for AL

By Houston Methodist FEATURING Angela Dispenzieri, Ronald Witteles

7 views

April 19, 2024

Houston Methodist's mission is to provide high quality, cost-effective health care that delivers the best ...
read more ↘ value to the people we serve in a spiritual environment of caring in association with internationally recognized teaching and research.

For a full listing of current courses offering CME credit, visit learn.houstonmethodist.org
To access our library of previously recorded activities, visit watch.houstonmethodist.org.

Please direct all further inquiries to cme@houstonmethodist.org
↖ read less

Comments 0

Cardiotoxicity in Breast Cancer – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

182 views

8 months ago

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

5.4K views

2 years ago

Cardio-Oncology: Definitions and Scope

University of Colorado Department of Medicine

L. Kondapalli

107 views

8 months ago

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

96 views

8 months ago

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

Przemyslaw Twardowski

668 views

1 year ago

How the Experts Manage: Cardiotoxicity and IO in NSCLC

MI&T Congressi

J. Remon Masip

107 views

3 months ago

ACC 2024 Insights: Pearls of Cardio-Oncology Screening and Management

ACC 2024 Insights

J. Johnson

137 views

6 months ago

ADT for Prostate Cancer and Cardiovascular Health Considerations

Andrew Hahn

466 views

1 year ago

Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclin…

Total Health

I. Rhea

103 views

8 months ago

Cardiotoxicity in Melanoma – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

50 views

8 months ago

Cardiotoxicity in RCC – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

84 views

8 months ago

Cardiac Disease in Breast Cancer: Background & Risk Factors

Total Health

I. Rhea

94 views

8 months ago

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

Monia Marchetti

403 views

1 year ago

Updates on Cardiac Amyloidosis: A “Rare” Disease Hiding in Plain Sig…

Courage and Innovation Symposium: Heart Failure & Heart Transplantation

N. Sarswat

1.3K views

2 years ago

FDA Perspective on New Therapies for Amyloidosis

Houston Methodist

R. Adigun

187 views

1 year ago

Clinical Presentation of Amyloidosis: Who to Suspect? - a 2022 Update

Scripps Health

R. Mohan

429 views

2 years ago

Cardio-Oncology in Breast Cancer: Treatment Options for Immune Check…

Total Health

I. Rhea

59 views

8 months ago

Updates on AL Amyloidosis Treatment: What is New in 2023

Dana-Farber Cancer Institute

G. Bianchi

287 views

1 year ago

Cancer and Cardiovascular Disease: The Conjoined Twins

MedNews Week

R. Moudgil

361 views

1 year ago

General Approach to Cardio-Oncology in Breast Cancer

Total Health

I. Rhea

23 views

8 months ago

AUTOPLAY

Login

Login

Join VuMedi

Panel Discussion: BMT As a Critical Treatment Option for AL

Recommended

Cardiotoxicity in Breast Cancer – Case Discussion

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Cardio-Oncology: Definitions and Scope

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

How the Experts Manage: Cardiotoxicity and IO in NSCLC

ACC 2024 Insights: Pearls of Cardio-Oncology Screening and Management

ADT for Prostate Cancer and Cardiovascular Health Considerations

Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclin…

Cardiotoxicity in Melanoma – Case Discussion

Cardiotoxicity in RCC – Case Discussion

Cardiac Disease in Breast Cancer: Background & Risk Factors

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

Updates on Cardiac Amyloidosis: A “Rare” Disease Hiding in Plain Sig…

FDA Perspective on New Therapies for Amyloidosis

Clinical Presentation of Amyloidosis: Who to Suspect? - a 2022 Update

Cardio-Oncology in Breast Cancer: Treatment Options for Immune Check…

Updates on AL Amyloidosis Treatment: What is New in 2023

Cancer and Cardiovascular Disease: The Conjoined Twins

General Approach to Cardio-Oncology in Breast Cancer